Figures & data
Figure 1. Structural analysis of HC-LC interface
![Figure 1. Structural analysis of HC-LC interface](/cms/asset/c4500c0b-3265-4fca-8f1c-1ace3ebe09fb/kmab_a_1870058_f0001_oc.jpg)
Figure 2. Schematic representation of the design of high-throughput Chain Selective Assessment methods (CSA)
![Figure 2. Schematic representation of the design of high-throughput Chain Selective Assessment methods (CSA)](/cms/asset/37a9d7f5-8ef4-4a0d-a3d9-dd76a2312045/kmab_a_1870058_f0002_oc.jpg)
Figure 3. High-throughput screening for low cross-pairing antibody combinations in cCSA experiment
![Figure 3. High-throughput screening for low cross-pairing antibody combinations in cCSA experiment](/cms/asset/13724035-bd34-4ec5-912e-cdc114fd0652/kmab_a_1870058_f0003_oc.jpg)
Figure 4. Predictability of HC/LC pairing in 4-chain hetero-IgGs
![Figure 4. Predictability of HC/LC pairing in 4-chain hetero-IgGs](/cms/asset/b006683e-995c-4907-b5e4-d620cb49ad34/kmab_a_1870058_f0004_oc.jpg)
Figure 5. High-throughput screening for cLC hetero-IgGs by ncCSA
![Figure 5. High-throughput screening for cLC hetero-IgGs by ncCSA](/cms/asset/7ee049d3-32aa-47d4-bc53-336c4f7c3467/kmab_a_1870058_f0005_oc.jpg)
Figure 6. Expression, purification and binding properties of two selected cLC hetero-IgG molecules
![Figure 6. Expression, purification and binding properties of two selected cLC hetero-IgG molecules](/cms/asset/b3076e70-88c4-4dde-b550-8546c50f5f8f/kmab_a_1870058_f0006_oc.jpg)